Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) (International Journal of Clinical Oncology, (2018), 23, 5, (965-973), 10.1007/s10147-018-1281-8)

For the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG)

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG) (International Journal of Clinical Oncology, (2018), 23, 5, (965-973), 10.1007/s10147-018-1281-8)'. Together they form a unique fingerprint.

Medicine & Life Sciences